Literature DB >> 22293227

Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina.

Ming-Jui Hung1, Wen-Jin Cherng, Ming-Yow Hung, Li-Tang Kuo, Chi-Wen Cheng, Chao-Hung Wang, Ning-I Yang, James K Liao.   

Abstract

OBJECTIVE: Although inhibition of Rho-associated coiled-coil containing protein kinase (ROCK) has been shown to prevent coronary vasospastic angina (CVA), direct evidence linking ROCK activity and CVA is lacking. Accordingly, we investigated whether ROCK activity is an independent marker for CVA and is altered after treatment with antispastic medications. METHODS AND
RESULTS: We prospectively studied 31 Taiwanese patients who were diagnosed with CVA and 33 control subjects. Subject demographics were recorded, and blood samples were obtained at baseline in all participants and in CVA patients after 3 months of antispastic treatment. Compared with control subjects, leukocyte ROCK activity was greater in CVA patients (136% versus 91%, P<0.001). A cutoff value for leukocyte ROCK activity of 104% predicted the presence of CVA with specificity and sensitivity rates of 88% and 84%, respectively. ROCK activity increased with the severity of CVA (P for trend<0.001). Following 3-month treatment of antispastic agents, leukocyte ROCK activity, high-sensitivity C-reactive protein, and interleukin-6 levels were reduced by 43%, 42% and 27%, respectively (P<0.05 for all).
CONCLUSIONS: Increased levels of leukocyte ROCK activity independently predicted the presence of CVA and correlated with CVA severity. Treatment with antispastic agents substantially reduced the level of leukocyte ROCK activity.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22293227      PMCID: PMC3312984          DOI: 10.1016/j.atherosclerosis.2012.01.001

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  25 in total

1.  Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions.

Authors:  H Suzuki; S Kawai; T Aizawa; K Kato; S Sunayama; R Okada; H Yamaguchi
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

2.  Long-term prognosis for patients with variant angina and influential factors.

Authors:  H Yasue; A Takizawa; M Nagao; S Nishida; M Horie; J Kubota; S Omote; K Takaoka; K Okumura
Journal:  Circulation       Date:  1988-07       Impact factor: 29.690

3.  Long-term prognosis of "variant" angina with medical treatment.

Authors:  S Severi; G Davies; A Maseri; P Marzullo; A L'Abbate
Journal:  Am J Cardiol       Date:  1980-08       Impact factor: 2.778

4.  A -786T>C polymorphism in the endothelial nitric oxide synthase gene reduces serum nitrite/nitrate levels from the heart due to an intracoronary injection of acetylcholine.

Authors:  Masafumi Nakayama; Michihiro Yoshimura; Tomohiro Sakamoto; Koji Abe; Megumi Yamamuro; Makoto Shono; Satoru Suzuki; Tsunenori Nishijima; Yoshihiro Miyamoto; Yoshihiko Saito; Kazuwa Nakao; Hirofumi Yasue; Hisao Ogawa
Journal:  Pharmacogenet Genomics       Date:  2006-05       Impact factor: 2.089

5.  Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina.

Authors:  K Kugiyama; H Yasue; K Okumura; H Ogawa; K Fujimoto; K Nakao; M Yoshimura; T Motoyama; Y Inobe; H Kawano
Journal:  Circulation       Date:  1996-08-01       Impact factor: 29.690

6.  Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.

Authors:  Ping-Yen Liu; Yen-Wen Liu; Li-Jen Lin; Jyh-Hong Chen; James K Liao
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690

7.  Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis.

Authors:  A Yilmaz; H Mahrholdt; A Athanasiadis; H Vogelsberg; G Meinhardt; M Voehringer; E-M Kispert; C Deluigi; H Baccouche; E Spodarev; K Klingel; R Kandolf; U Sechtem
Journal:  Heart       Date:  2008-01-29       Impact factor: 5.994

8.  Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.

Authors:  Masao Takemoto; Jianxin Sun; Junko Hiroki; Hiroaki Shimokawa; James K Liao
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

9.  ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury.

Authors:  Kensuke Noma; Yoshiyuki Rikitake; Naotsugu Oyama; Guijun Yan; Pilar Alcaide; Ping-Yen Liu; Hongwei Wang; Daniela Ahl; Naoki Sawada; Ryuji Okamoto; Yukio Hiroi; Koichi Shimizu; Francis W Luscinskas; Jianxin Sun; James K Liao
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

10.  Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase.

Authors:  Keiji Oi; Hiroaki Shimokawa; Junko Hiroki; Toyokazu Uwatoku; Kohtaro Abe; Yasuharu Matsumoto; Yasuhiro Nakajima; Katsuyuki Nakajima; Sanae Takeichi; Akira Takeshita
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-03-25       Impact factor: 8.311

View more
  15 in total

Review 1.  Involvement of Rho GTPases and their regulators in the pathogenesis of hypertension.

Authors:  Gervaise Loirand; Pierre Pacaud
Journal:  Small GTPases       Date:  2014-10-31

2.  Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial.

Authors:  Tatsuya Maruhashi; Kensuke Noma; Noritaka Fujimura; Masato Kajikawa; Takeshi Matsumoto; Takayuki Hidaka; Ayumu Nakashima; Yasuki Kihara; James K Liao; Yukihito Higashi
Journal:  Hypertens Res       Date:  2015-03-05       Impact factor: 3.872

3.  Interleukin-6 promotor polymorphisms and coronary vasospastic angina in Han Chinese.

Authors:  Ying Wang; Gang Li; Ya-Min Su; Hai-Yan Pan; Hai-Hua Geng; Meng-Kan Fan; Min Pan
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 4.  Pleiotropic Effects of Statins on the Cardiovascular System.

Authors:  Adam Oesterle; Ulrich Laufs; James K Liao
Journal:  Circ Res       Date:  2017-01-06       Impact factor: 17.367

Review 5.  Coronary Vasospastic Angina: Current Understanding and the Role of Inflammation.

Authors:  Ming-Jui Hung; Wen-Jin Cherng
Journal:  Acta Cardiol Sin       Date:  2013-01       Impact factor: 2.672

6.  An atypical case of vasospastic angina: demonstrating the usefulness of Holter monitoring.

Authors:  Naveen Chandra Ganiga Sanjeeva; Ranjan K Shetty; Sumit Agarwal
Journal:  BMJ Case Rep       Date:  2015-08-25

7.  Elevated rho-kinase activity as a marker indicating atherosclerosis and inflammation burden in polyvascular disease patients with concomitant coronary and peripheral arterial disease.

Authors:  Ming Dong; Xin Jiang; James K Liao; Bryan P Yan
Journal:  Clin Cardiol       Date:  2013-03-28       Impact factor: 2.882

Review 8.  Rho Kinases and Cardiac Remodeling.

Authors:  Toru Shimizu; James K Liao
Journal:  Circ J       Date:  2016-06-01       Impact factor: 2.993

Review 9.  Coronary artery spasm: review and update.

Authors:  Ming-Jui Hung; Patrick Hu; Ming-Yow Hung
Journal:  Int J Med Sci       Date:  2014-08-28       Impact factor: 3.738

10.  Impact of Asthma on the Development of Coronary Vasospastic Angina: A Population-Based Cohort Study.

Authors:  Ming-Jui Hung; Chun-Tai Mao; Ming-Yow Hung; Tien-Hsing Chen
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.